Tenax CFO Thomas R. Staab II buys USD 10,982.63 in common shares

• Tenax Therapeutics CFO Thomas R. Staab II bought 5,675 common shares at USD 1.94, raising his direct stake to 15,675 shares.
• Staab also reported beneficial ownership of 450,000 stock options with an exercise price of USD 11.95.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenax Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-392319), on September 15, 2026, and is solely responsible for the information contained therein.